(Q46565418)

23 December 2017

title

Effect of CYP2C19 and MDR1 polymorphisms on cure rate in patients with acid-related disorders with Helicobacter pylori infection (English)

1 reference

23 December 2017

1 reference

Andrzej Pawlik

4

0 references

Teresa Starzyńska

Teresa Starzyńska

3

0 references

Krzysztof Safranow

Krzysztof Safranow

5

0 references

Marek Drozdzik

7

Marek Droździk

1 reference

23 December 2017

Barbara Gawronska-Szklarz

1

Barbara Gawrońska-Szklarz

1 reference

23 December 2017

author name string

Joanna Wrześniewska

2

1 reference

23 December 2017

Katarzyna Ferenc

6

1 reference

23 December 2017

publication date

23 June 2005

1 reference

23 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

23 December 2017

volume

61

1 reference

23 December 2017

issue

5-6

1 reference

23 December 2017

page(s)

375-379

1 reference

23 December 2017

Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

cites work

1 reference

12 December 2020

Cure of refractory duodenal ulcer and infection caused by Helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient

1 reference

12 December 2020

The clinical role of cytochrome p450 genotypes in Helicobacter pylori management

1 reference

12 December 2020

Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism

1 reference

12 December 2020

CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori

1 reference

12 December 2020

Effect of clarithromycin on renal excretion of digoxin: interaction with P-glycoprotein

1 reference

12 December 2020

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

1 reference

12 December 2020

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.

1 reference

12 December 2020

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

12 December 2020

Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of Gastroenterology

1 reference

12 December 2020

Frequencies of the defective CYP2C19 alleles responsible for the mephenytoin poor metabolizer phenotype in various Oriental, Caucasian, Saudi Arabian and American black populations

1 reference

12 December 2020

Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin

1 reference

12 December 2020

Interaction of proton pump inhibitors with cytochromes P450: consequences for drug interactions.

1 reference

12 December 2020

Cytochrome P-450 3A4: regulation and role in drug metabolism

1 reference

12 December 2020

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

12 December 2020

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

1 reference

12 December 2020

Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations

1 reference

12 December 2020

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

1 reference

12 December 2020

Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype

1 reference

12 December 2020

Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.

1 reference

12 December 2020

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

1 reference

12 December 2020

A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested

1 reference

12 December 2020

Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole

1 reference

12 December 2020

Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein

1 reference

12 December 2020

A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole

1 reference

12 December 2020

Potential role of P-glycoprotein in affecting hepatic metabolism of drugs

1 reference

12 December 2020

Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs

1 reference

12 December 2020

The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.

1 reference

12 December 2020

Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese

1 reference

12 December 2020

The CYP2C19 enzyme polymorphism

1 reference

12 December 2020

Effect of omeprazole 10 mg on intragastric pH in three different CYP2C19 genotypes, compared with omeprazole 20 mg and lafutidine 20 mg, a new H2-receptor antagonist

1 reference

12 December 2020

10.1007/S00228-005-0901-1

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017